Randomized, double-blind, placebo-controlled, safety, PK/PD and preliminary efficacy study of
intravenous IC14 in adult patients in a dengue-endemic region presenting with fever > 38°C
for < 48 hours with a positive NS1 strip assay or reverse-transcriptase polymerase chain
reaction assay for dengue virus.